Asset Sadhu
Funds/Mahindra Manulife Multi Cap Fund

Mahindra Manulife Multi Cap Fund

Mahindra Manulife Mutual Fund·Multi Cap Fund·vs Nifty 500 Multicap 50:25:25 TRI

The fund maintains a quality-biased stance with meaningful overweight to pharmaceuticals and financial services, signaling conviction in resilient sectors. The recent churn—exiting high-beta financials like Bajaj Finserv while adding Adani Enterprises and Aditya Birla Capital—suggests a tactical shift toward large-cap stability within the multi-cap mandate. The tight top-10 concentration at 25.4% reflects disciplined stock-picking rather than index-hugging, though the manager appears moderately cautious with minimal cash deployment.

Portfolio analysis · April 2026

PlanNAV1M1Y3Y CAGR5Y CAGR
Direct Growth₹42.8217
Regular Growth₹36.4940+2.08%+6.42%+19.99%+17.69%
Direct IDCW₹30.6464
Regular IDCW₹24.8926
Returns above 1Y are CAGR. Direct plan rows highlighted. NAV from AMFI.
Holdings
82
Top 5 Weight
14.68%
Top 10 Weight
25.45%
Max Position
3.70%
Conviction Bets
9
Gini
0.311
Large Cap
36.75%
Mid Cap
30.26%
Small Cap
27.44%
Top Sector
Pharmaceuticals & Biotechnology
Sector Count
35
HHI (bps)
15,762
Highly Differentiated
Active Share
72.45%
vs peer portfolio
Weight Overlap
25.15%
with avg peer
Cosine Similarity
0.412
portfolio angle
Peer Count
30
funds in category

Active Share = ½Σ|wfund − wpeer|, computed using leave-one-out peer portfolio within SEBI category.

Holdings: 8184+9 added6 removed34 weight shifts ≥ 0.1%
StockWeight
Adani Enterprises Limited2.39%
Aditya Birla Capital Limited2.10%
Godfrey Phillips India Limited1.05%
Max Financial Services Limited0.74%
Avenue Supermarts Limited0.53%
Vedanta Iron And Steel Limited0.34%
Malco Energy Limited0.34%
Talwandi Sabo Power Limited0.34%
Vedanta Aluminium Metal Limited0.34%
#Holding% to NAV
1
Glenmark Pharmaceuticals Limited
INE935A01035
3.70%
2
Larsen & Toubro Limited
INE018A01030
3.28%
3
Divi's Laboratories Limited
INE361B01024
2.88%
4
Polycab India Limited
INE455K01017
2.43%
5
Adani Enterprises Limited
INE423A01024
2.39%
6
BSE Limited
INE118H01025
2.26%
7
UltraTech Cement Limited
INE481G01011
2.25%
8
Neuland Laboratories Limited
INE794A01010
2.18%
9
Aditya Birla Capital Limited
INE674K01013
2.10%
10
Nippon Life India Asset Management Limited
INE298J01013
1.98%
11
APL Apollo Tubes Limited
INE702C01027
1.92%
12
State Bank of India
INE062A01020
1.91%
13
Laurus Labs Limited
INE947Q01028
1.88%
14
Voltamp Transformers Limited
INE540H01012
1.85%
15
Bandhan Bank Limited
INE545U01014
1.84%
16
Shriram Finance Limited
INE721A01047
1.83%
17
Bajaj Auto Limited
INE917I01010
1.75%
18
Angel One Limited
INE732I01021
1.72%
19
Aarti Industries Limited
INE769A01020
1.70%
20
ICICI Bank Limited
INE090A01021
1.67%
Pharmaceuticals & Biotechnology12.0%
Banks9.9%
Industrial Products9.4%
Capital Markets7.3%
Finance6.7%
Cement & Cement Products5.2%
IT - Software4.8%
Automobiles4.5%
Consumer Durables3.6%
Chemicals & Petrochemicals3.3%

Top 10 sectors by % to NAV. Excludes derivatives.

How many stocks does Mahindra Manulife Multi Cap Fund hold?

Mahindra Manulife Multi Cap Fund holds 82 stocks as per the latest AMFI portfolio disclosure. The top 5 positions account for 14.68% of NAV.

What is the largest holding in Mahindra Manulife Multi Cap Fund?

The largest position in Mahindra Manulife Multi Cap Fund is Glenmark Pharmaceuticals Limited, accounting for 3.70% of NAV in the Pharmaceuticals & Biotechnology sector.

Is Mahindra Manulife Multi Cap Fund a concentrated or diversified fund?

With a Gini coefficient of 0.311, Mahindra Manulife Multi Cap Fund is well-diversified. The HHI concentration index is 15,762 bps, which is above the 2500 bps threshold for high concentration. The top 5 holdings together make up 14.68% of the portfolio.

What is the market cap allocation of Mahindra Manulife Multi Cap Fund?

Based on SEBI's AMFI classification, Mahindra Manulife Multi Cap Fund's equity portfolio is split as: Large Cap: 36.75%, Mid Cap: 30.26%, Small Cap: 27.44%. This reflects the fund's positioning within the market cap spectrum.

Which sectors does Mahindra Manulife Multi Cap Fund invest in most?

Mahindra Manulife Multi Cap Fund has the highest allocation to Pharmaceuticals & Biotechnology (12.02%), Banks (9.90%), Industrial Products (9.42%). The fund is invested across 35 sectors in total.

How actively managed is Mahindra Manulife Multi Cap Fund compared to other Multi Cap Fund funds?

Mahindra Manulife Multi Cap Fund has an Active Share of 72.45%, classifying it as "Highly Differentiated" among 30 Multi Cap Fund peers. This means the fund takes significantly different stock positions compared to its category peers.

What changed in Mahindra Manulife Multi Cap Fund's portfolio in the latest month?

Between 2026-03-31 and 2026-04-30, Mahindra Manulife Multi Cap Fund added 9 new stocks (including Adani Enterprises Limited) and exited 6 stocks (including Indus Towers Limited). Total holding count increased from 81 to 84 stocks.